Matrix metalloproteinase-2 and -7 expression in colorectal cancer

Journal of the Korean Society of Coloproctology

Volumn 27, Issue 3, 2011, Pages 133-139

  Hong, Seong Woo ^a   Kang, Yun Kyung ^a   Lee, Byungmo ^a   Lee, Woo Yong ^a   Jang, Yeo Gu ^a   Paik, In Wook ^a   Lee, Hyucksang ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Colorectal neoplasms; Immunohistochemistry; Matrix metalloproteinases; Prognosis

Indexed keywords

GELATINASE A; MATRILYSIN; MATRIX METALLOPROTEINASE;

ARTICLE; CANCER STAGING; COLON RESECTION; COLORECTAL CANCER; DISEASE FREE SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 80051532484     PISSN: 20937822     EISSN: 20937830     Source Type: Journal    
DOI: 10.3393/jksc.2011.27.3.133     Document Type: Article

References (27)

1. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010;141:52-67.
2. Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 2009;27:5287-97.
3. National Cancer Information Center. Cancer incidence rate 2008 [Internet]. Goyang: National Cancer Information Center; c2008 [cited 2011 June 1]. Available from: http://www.cancer.go.kr/cms/statics/incidence/index.html.
4. Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ. Adjuvant treatment of colorectal cancer. CA Cancer J Clin 2007;57:168-85. (Pubitemid 46798625)
5. Sun XF, Zhang H. Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas. Mol Cancer 2006;5:43.
6. Leeman MF, Curran S, Murray GI. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 2003;201:528-34. (Pubitemid 38256401)
7. van der Jagt MF, Wobbes T, Strobbe LJ, Sweep FC, Span PN. Metalloproteinases and their regulators in colorectal cancer. J Surg Oncol 2010;101:259-69.
8. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003;200:448-64. (Pubitemid 36818245)
9. Newell KJ, Matrisian LM, Driman DK. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis. Mol Carcinog 2002;34:59-63. (Pubitemid 34606507)
10. Zeng ZS, Shu WP, Cohen AM, Guillem JG. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin Cancer Res 2002;8:144-8. (Pubitemid 34101470)
11. Brand K, Baker AH, Perez-Cantó A, Possling A, Sacharjat M, Geheeb M, et al. Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res 2000;60:5723-30.
12. Langenskiold M, Holmdahl L, Falk P, Ivarsson ML. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int J Colorectal Dis 2005;20:245-52. (Pubitemid 40553003)
13. Schwandner O, Schlamp A, Broll R, Bruch HP. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer. Int J Colorectal Dis 2007;22:127-36. (Pubitemid 44964015)
14. Hilska M, Roberts PJ, Collan YU, Laine VJ, Kossi J, Hirsimäki P, et al. Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer. Int J Cancer 2007;121:714-23. (Pubitemid 47106199)
15. Sundov Z, Tomić S, Vilović K, Kunac N, Kalebić M, Bezić J. Immunohistochemically detected high expression of matrix metalloproteinase-2 as predictor of poor prognosis in Duke's B colon cancer. Croat Med J 2008;49:636-42.
16. Adachi Y, Yamamoto H, Itoh F, Arimura Y, Nishi M, Endo T, et al. Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer 2001;95:290-4. (Pubitemid 32847038)
17. Ko K, Yazumi S, Yoshikawa K, Konda Y, Nakajima M, Chiba T, et al. Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact Co-cultures. Int J Cancer 2000;87:165-71. (Pubitemid 30434340)
18. Ornstein DL, MacNab J, Cohn KH. Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer. Clin Exp Metastasis 1999;17:205-12. (Pubitemid 29360898)
19. Wang WS, Chen PM, Wang HS, Liang WY, Su Y. Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis 2006;27:1113-20.
20. Papadopoulou S, Scorilas A, Arnogianaki N, Papapanayiotou B, Tzimogiani A, Agnantis N, et al. Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa. Tumour Biol 2001;22:383-9. (Pubitemid 34062950)
21. Wang FQ, So J, Reierstad S, Fishman DA. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int J Cancer 2005;114:19-31. (Pubitemid 40194305)
22. Li M, Li JY, Zhao AL, Gu J. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology 2007;73:52-7. (Pubitemid 351465600)
23. Kim TD, Song KS, Li G, Choi H, Park HD, Lim K, et al. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. BMC Cancer 2006;6:211.
24. Taniwaki K, Fukamachi H, Komori K, Ohtake Y, Nonaka T, Sakamoto T, et al. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice. Cancer Res 2007;67:4311-9.
25. Cho YB, Lee WY, Song SY, Shin HJ, Yun SH, Chun HK. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer. Hum Pathol 2007;38:1603-10.
26. Maurel J, Nadal C, Garcia-Albeniz X, Gallego R, Carcereny E, Al-mendro V, et al. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer 2007;121:1066-71. (Pubitemid 47101644)
27. Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res 2004;10:8229-34. (Pubitemid 40053382)